Rezolute (previously AntriaBio) Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Rezolute (previously AntriaBio)'s estimated annual revenue is currently $10.5M per year.(i)
  • Rezolute (previously AntriaBio)'s estimated revenue per employee is $155,000

Employee Data

  • Rezolute (previously AntriaBio) has 68 Employees.(i)
  • Rezolute (previously AntriaBio) grew their employee count by 39% last year.

Rezolute (previously AntriaBio)'s People

NameTitleEmail/Phone
1
CEO & FounderReveal Email/Phone
2
VP, Global Product SupplyReveal Email/Phone
3
VP & Head Clinical OperationsReveal Email/Phone
4
VP New Product PlanningReveal Email/Phone
5
VP Clinical OperationsReveal Email/Phone
6
VP, QualityReveal Email/Phone
7
VP, Drug Discovery and Pharmaceutical SciencesReveal Email/Phone
8
VP and Head QualityReveal Email/Phone
9
VP & Head FinanceReveal Email/Phone
10
Director Quality ComplianceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Rezolute (previously AntriaBio)?

Rezolute is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with metabolic and orphan diseases. For more information, visit: www.rezolutebio.com.

keywords:N/A

N/A

Total Funding

68

Number of Employees

$10.5M

Revenue (est)

39%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Rezolute (previously AntriaBio) News

2022-04-17 - Rezolute (NASDAQ:RZLT) Stock Rating Upgraded by Zacks ...

Rezolute, Inc., formerly known as AntriaBio, Inc., is based in LOUISVILLE, United States. “ Get Rezolute alerts: Separately, Roth Capital lifted...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.1M68-3%N/A
#2
$13.2M70N/AN/A
#3
$8.8M700%N/A
#4
$13.9M70-29%N/A
#5
$15.8M708%N/A